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of experiences in the identification, care and 
treatment, and management of young children 
who are HIV-positive. In addition, scarce 
information is available on how communities, 
caregivers, and health providers can work together 
to improve access to treatment for children living 
with HIV. 
To address these gaps, the Horizons Program 
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To read more about this study, go to the full report, 
http://www.popcouncil.org/pdfs/horizons/sapedssa.pdf
A rapid situational analysis of the 
antiretroviral (ARV) rollout in South 
Africa found that several ARV programs 
are treating children successfully. 
However, all institutions surveyed 
identified a large number of concerns 
and challenges that need to be 
overcome in order to improve care for 
children living with HIV. Key actions 
required include early identification of 
HIV-infected children, effective referral, 
standardized training in pediatric HIV 
management for health professionals, 
and increased community awareness 
and support.
In 2005, more than half a million children died 
of AIDS, the vast majority of whom lived in 
the developing world (UNAIDS 2005). In sub-
Saharan Africa, AIDS has become one of the 
leading causes of death among children under the 
age of five years. Yet despite increased availability 
of antiretroviral therapy (ART), children have 
been largely ignored or excluded from treatment 
initiatives. 
While efforts to get more children on treatment 
are increasing, important information is lacking 
to guide program and policy implementation. 










In a country where 40 percent of deaths in children 
under age five are attributed to HIV, expanding 
pediatric access to treatment is critical.
a rapid situational analysis in 2005 
of pediatric HIV treatment sites in 
South Africa. In 2003, the South 
African government approved a 
plan for a national HIV treatment 
program with the goal of at least one 
service delivery point in each district 
providing treatment. The government 
guidelines emphasized providing 
treatment for both adults and 
children and, based on reports from 
a number of site managers who were 
the first to provide pediatric HIV care, the initial 
effort resulted in a significant number of children 
initiating treatment. This was especially important in 
a country where HIV is the cause of an estimated 40 
percent of deaths in children under five years of age 
(Dorrington et al. 2004). 
The rapid situational analysis details what is 
happening on the ground—challenges and lessons 
learned at key pediatric HIV care sites in South 
Africa—in order to understand how children have 
been affected by the ARV rollout and what can be 
done to reach the thousands more that should be on 
treatment. 
Methods
As part of the situational analysis, a policy review 
was conducted which focused on how pediatric 
care is addressed in the “Operational plan for 
comprehensive HIV and AIDS care, management 
and treatment for South Africa, November 2003” 
(South Africa Department of Health 2003) and 
other key national documents. 
The researchers also employed qualitative and 
quantitative methods to collect data at ARV program 
sites. They conducted facility observations and 
interviewed facility managers, different cadres of 
health care workers (doctors, nurses, pharmacists, 
social workers, counselors, dieticians), and caregivers 
of children on ART. At a total of 16 sites offering 
pediatric ARV services, 7 facility managers, 67 other 
categories of health care workers, and 126 caregivers 
were interviewed.
The 16 sites varied in their overall 
character and location within 
the health system, including, for 
example, a pediatric clinic at a 
tertiary institution in an urban 
setting and a combined adult and 
pediatric clinic at a primary-level 
rural facility. As of March 2005 
the sites were providing ART to 
approximately 1,300 children. About 
60 percent of these children were 
under six years of age. Table 1 shows 
the pediatric HIV case loads and the number of 
children receiving ART in the study sites.
Key Findings
The national policy framework lacks clear 
guidance on the comprehensive management of 
pediatric HIV.
The policy review showed that current policy 
documents cover a wide range of services and 
interventions for HIV-infected children. However, 
existing policies are scattered over several documents, 
are not uniform in their presentation, and are 
underdeveloped in certain areas (e.g., lack of specific 
recommendations for managing infected infants, 
adolescents, and children without reliable caregivers). 
Therefore, they do not clearly guide the development 
of comprehensive services for HIV-infected children.
 
Health workers trained in pediatric HIV 
management are vital to the ARV rollout.
All facility managers and health care workers who 
were interviewed about their experiences and 
perceptions of the ARV rollout spoke about the 
challenges they faced in their effort to expand access 
to treatment for HIV-infected children. Across 
all facilities, respondents cited a lack of staff as a 
major obstacle to reaching more children with the 
treatment they need. 
Health care workers also viewed a lack of specific 
pediatric training as an obstacle. Most doctors 
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This low confidence in dealing with young children 
was particularly evident in the area of taking blood. 
Nurses across study sites were often reluctant to draw 
blood from children under the age of six, a major 
barrier to the rollout of ARV treatment for children 
and infants. 
Currently nurses are refusing to take bloods on 
all children less than 6 years which impacts 
negatively on the screening process for ARV 
readiness. The children now have to be screened 
by the doctors in the ARV clinic, sent back to the 
fully booked drug readiness program, and then 
back to the ARV clinic for their ARV treatment 
to be initiated. 
Fieldworker observation, 
district hospital site
In addition, several nurses expressed that managing 
ARVs for very young children is challenging because 
the dosing calculations are complicated and change 
frequently as children grow. 
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reported having received no or limited formal 
training in the area of pediatric HIV management, 
even during any ARV rollout training they received. 
Instead, they generally relied on self-study, such 
as on-line courses, and mentorship training from 
specialists to build their skills in the area. Nurses had 
varying levels of HIV-specific experience and limited 
pediatric training, with the majority receiving on-
the-job training in these areas from doctors.
This lack of training in managing ARVs for children 
has resulted in many service providers having low 
levels of confidence in treating and managing 
children. 
A lot of doctors are not willing to work with 
children and are scared of the rollout, they think 
that with children it’s more difficult…. I know 
for instance our sisters [nurses] don’t see children 
and some of the doctors don’t see children. 
Doctor, tertiary care facility,  
urban setting
Table 1  Pediatric HIV case loads and patients on ART at study sites (as of March 2005)













Primary level (4 clinics and district hospital)
105   39 50
E.Cape 2
Tertiary level (district hospital)
Not available#   57 Not known
W.Cape 1
Tertiary level (hospital site)
300 351 85
W.Cape 2
Primary level (3 clinics)
248 157 68
Gauteng
Tertiary and primary level (hospital site and 1 clinic)
630 550 60
KZN
Secondary level (district hospital)
135 108 67
Free State
Tertiary and primary level (hospital site and referral clinic sites)
184   44 57
#“The ARV clinic does not have many children not on ARVs—ARV initiation is quick in patients able to cope…we are unable to provide the actual number 
of HIV infected not on treatment.” –Facility manager
I treat opportunistic infections and manage 
adults on ARVs. I can do the children if they 
are above eight years…below that age they’re on 
syrups…syrups are a bit complicated and they 
need a more professional person to do it. 
Nurse, primary care facility, 
peri-urban setting
Pharmacists have expanded their role to 
include counseling and adherence training for 
caregivers.
The usual roles of pharmacists of dispensing 
medications and counseling patients have been 
expanded due to the nature of ART and the risks of 
drug resistance. Pharmacists reported spending more 
of their time packing, labeling, color-coding bottles 
for easy recognition, and color-coding medication 
administration tools like syringes to facilitate ease 
of measurement. They also spent considerable time 
explaining to children’s caregivers how important it is 
that ARVs are taken correctly and ensuring that they 
understood the dosing requirements. 
Because of changes in dosing due to a child’s 
growth, caregivers needed to be re-trained at almost 
every visit, especially for a young child. At the 
same time, pharmacists found that supporting and 
assessing adherence in children was difficult. Some 
pharmacists counted and measured returned pills 
and syrups. However, this was not always an accurate 
measure of adherence.
…you actually have no way of telling and seeing 
if the mom is [measuring] the exact quantity or 
giving the child the exact quantity. 
Pharmacist, tertiary care facility, 
urban setting
ARV drug procurement and stock control was 
another significant task that pharmacists at most sites 
were responsible for overseeing. Procuring adequate 
drug supplies can prove problematic since it is 
difficult to predict the number of children requiring 
medication. 
…at this stage we don’t have a clue how many 
children come, some weeks you get 10 and the 
next none, so I don’t know how to order the 
amount of stock.
Pharmacist, tertiary care facility, 
urban setting
In addition, the fear of running out of drugs may 
lead to stockpiling, which can cause expired drugs 
to end up on the shelves. At the same time, because 
each child requires large amounts of antiretrovirals 
(mostly in syrup form), this can result in storage 
problems at pharmacies and limit the amount of 
drugs that can be ordered at a time at particular sites.
Early referral of children to treatment 
programs is critical.
Health workers were interviewed about the referral 
of children to their care and the identification of 
HIV-infected children in need of treatment. The 
majority of children on treatment were referred after 
they presented with clinical symptoms at primary 
care facilities or hospital in-patient wards. As a result, 
a large number of these children were ill when they 
began treatment. Results from the caregivers survey 
supported these findings (Figure 1). Only a few 
patients were brought in for testing and care by their 
parents who were receiving treatment.
Health workers agreed that prevention of mother-
to-child transmission (PMTCT) programs, primary 
care clinics, and voluntary counseling and testing 
(VCT) services were ideally the optimal sources of 
treatment referral for the majority of HIV-infected 
children. They noted that there is often a breakdown 
in the follow-up of an HIV-exposed infant between 
the time when the mother delivers and when other 
services are rendered at another health facility, for 
example during routine immunizations at a primary 
care clinic. One doctor shared his frustration with 
the system:
We know there are children from the PMTCT 
program who should have been on ARVs so we 
are grossly undersupplying ARVs to children and 
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our PMTCT program is not working at this 
site [to identify these children] and as a result 
children are dying…. 
Doctor, tertiary care facility,
peri-urban setting
In addition, doctors at tertiary institutions stressed 
that primary level clinics should optimally be the 
place where children are identified, assessed, and 
treated, and that their only contact with tertiary 
institutions should be for complications and 
hospitalization. 
...I think [our] role in the program is to support, 
mentor, and develop capacity of…primary sites 
when it comes to the management of children 
infected and those requiring ARVs. [Our] specific 
clinic function will come to the management of 
more complicated cases, where patients are ill, 
or for the very young children under six months 
but certainly [tertiary institutions] are not 
appropriate for the management of children who 
are well and stable on ARVs…. 
Doctor, tertiary care facility,  
urban setting 
However, assessing and initiating treatment for 
children requires specific skills such as blood-taking 
from infants. Beyond that there is the need for CD4 
counts and viral load tests, which require laboratory 
services. While recognizing that primary care is 
most accessible to the community, health providers 
also noted the current lack of capacity at that level 
to fulfill the range of services required to identify 
children in need of ARVs and offer them treatment.
Socioeconomic barriers are a serious obstacle 
to treatment access and adherence.
During interviews health workers mentioned a 
number of socioeconomic barriers that their patients 
face that negatively impact access and adherence to 
treatment for children. For example, the majority of 
children in the country are managed at secondary 
and tertiary centers or at dedicated HIV treatment 
facilities, which are not necessarily located in the 
communities where they live. Thus the cost of 
transportation can become a barrier to reaching the 
clinic for necessary visits.  











Mother received PMTCT services
The circumstances surrounding a child’s living 
arrangements can be an obstacle. Social workers 
reported that a large bulk of their work entailed 
ensuring that caregivers can access government 
grants, such as child support, care dependency, and 
foster child grants. But access to government grants 
by caregivers for themselves or on behalf of the 
children is hampered by a lack of identity documents 
and birth certificates or the fact that many children 
do not have legal guardians. 
I think social services need to be basically 
upgraded tremendously to support these children 
and their families who are on treatment, just like 
the issue of getting a mom an identity document 
so she can access a grant or basic things like 
that—that I can’t help with; but somebody has to 
help these people!
Doctor, primary care facility, 
urban setting 
The ill health and/or death of parents can negatively 
impact a child’s likelihood of receiving treatment 
and/or continuing to receive their medication. 
Multiple caregivers and instability of residence often 
add to the challenge of continuing many children on 
treatment. 
…they are not always brought by their biological 
parents, there’s always a change of caregivers, an 
aunt and the grandmother does not give the same 
information so every time we have to start from 
the beginning and have to explain what we have 
explained before….
Doctor, primary care facility, 
urban setting 
Increased community involvement and 
education are needed to foster treatment access 
for children.
In some sites it was reported that community 
members were not aware that ARV services were 
available or recommended for children. In fact, 
some doctors felt that there is widespread skepticism 
surrounding treatment of children and concerns over 
negative effects of the drugs on them. 
I don’t think we’ve had enough education in 
terms of the access [to treatment]…and then 
we probably need to change the perception that 
ARVs are not good. I don’t know how we can do 
that…it all started in the media, maybe we can 
go back to the media to change it…because ARVs 
to everyone are still a mystery—it’s a mystery that 
people don’t want to delve into…. 
Doctor, tertiary care facility, 
peri-urban setting
Interestingly, when asked what they saw as the major 
ways to increase treatment access for children, most 
nurses interviewed did not mention mechanisms 
within the health system, but rather community 
interventions such as public awareness campaigns 
and patient, caregiver, and teacher education 
regarding the availability and benefits of treatment 
for children. More than one respondent emphasized 
the need for information to give their patients 
about ARVs and how they can benefit children in 
particular. 
I’m sure the ARV rollout started before 
community mobilization, especially in rural 
areas, because they don’t know about ARVs, even 
if it’s for the adult and also the fact that these 
children, most of these children you’ll find that 
it’s not their mothers who look after them, it’s the 
grannies, it’s the people who have no knowledge 
of HIV and AIDS…who didn’t even know that 
the child is HIV-positive….
Nurse, tertiary care facility, 
peri-urban setting
Caregivers are essential to the successful 
management of ARVs for children, yet they are 
often heavily burdened by HIV.
Providing treatment to children is additionally 
complicated because of the need to involve caregivers 
in the entire process—from diagnosis, referral, and 
initiation of treatment to regular follow-up care and 
consistent administration of drugs. 
The primary caregivers interviewed were mainly 
biological mothers, grandmothers, and aunts. Most 
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reported that the children in their care had been 
referred from a community clinic to the ARV site, 
and had been tested for HIV because they were 
either chronically ill or hospitalized. Only 5 percent 
had been tested because their mothers were in a 
PMTCT program. 
Many families caring for HIV-positive children were 
already heavily burdened with HIV infection. Three 
out of four caregivers reported that there was at least 
one person in the household who was infected with 
HIV in addition to the child. Of this group, just 
over half (52 percent) were on ARVs. Though 56 
percent of those on treatment received ARVs from 
the same clinic as the child, only 38 percent of the 
group had the same appointment dates as the child. 
Yet the majority (86 percent) of caregivers preferred 
household members to have their appointment dates 
on the same day.
Adherence to the medications was generally good: 96 
percent of children had received their medication on 
the morning of the interview; however, 15 percent 
had missed one or more doses in the previous week. 
Reasons for the missed doses included the child’s 
poor health status, the caregiver had forgotten, 
the time had passed, the child had vomited, or the 
medications were finished. 
Recommendations
Despite having made progress in meeting the 
treatment needs of HIV-infected children, the 
dedicated professionals surveyed identified many 
concerns and challenges that need to be overcome to 
meet South Africa’s treatment goals. This will require 
action from key individuals at institutions and in 
provincial and national HIV directorates—actions 
that are relevant for South Africa as well as for other 
countries in the region that are seeking to expand 
treatment access and service delivery for children 
living with HIV.
First, standardized training for doctors and nurses 
from institutions at all health care levels must be 
implemented to give them the expertise and clinical 
competence they need to manage young children. 
This study revealed that many children younger than 
the age of six years were being treated at tertiary 
facilities due to a lack of expertise at primary level 
facilities. Caring for HIV-infected infants is complex 
because they often have additional medical problems, 
knowledge among health workers of the use of ART 
in the very young is incomplete, and their drug dose 
calculations may require the use of body surface 
area calculations. Plus obtaining the blood samples 
needed to monitor young children requires skill and 
experience. 
Second, the follow up of exposed children and links 
between PMTCT programs and other childhood 
and development services must be strengthened so 
that these children do not get lost in the system. 
Preventing pediatric HIV infection through a 
comprehensive PMTCT program remains the 
most effective strategy to modify the course of 
the pediatric HIV epidemic in South Africa. 
Unfortunately there still will be children who are 
exposed to HIV and subsequently in need of care 
and treatment. Identifying and monitoring these 
HIV-exposed children from birth will ensure early 
intervention and maximize benefits to their health 
while minimizing the burden on the health system.
Third, national pediatric adherence guidelines need 
to be developed that emphasize treatment literacy 
training targeted to caregivers of pediatric patients as 
well as the provision of medication administration 
tools, such as color-coded bottles and dosing 
syringes. These will help ensure the high levels of 
adherence critical for achieving the goal of ART—
survival and improved quality of life. In addition, a 
family-centered model of care should be considered 
to encourage adherence and the integration of 
services.
Fourth, routine statistics that disaggregate children 
by age and sex should be collected from all sites in 
South Africa to flag areas that are either not treating 
children or are falling below acceptable enrollment 
rates. These areas could then be targeted for 
appropriate support and training. 
   
Finally, the Department of Health should take the 
lead in bringing together other key players to foster 
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a collaborative effort to provide social support and 
develop interventions for children without regular 
or reliable caregivers, and to promote community 
awareness of treatment through information 
dissemination campaigns. Furthermore, gaps in 
policy guidelines should be addressed.
Results from the rapid situational analysis have been 
disseminated to the study sites to guide them in 
strengthening their services. They were also shared 
with advocacy groups and government policymakers 
to inform their ongoing ARV rollout planning 
processes. Horizons is planning follow-on studies 
that will examine family-centered models of service 
delivery and the identification of orphans and 
vulnerable children in the community in need of 
care.
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